Named from the Greek psyche to convey the mind, soul, or essence of life, combined with –delic (derived from manifest, or clear) the mystery of a psychedelic can hardly fail to pique initial intrigue — but it wouldn’t be studied for long without promising, tangible results.
Luckily for psychedelics — and perhaps for humankind — those results have been found in abundance. Everywhere from Imperial College London to the University of Zurich is now taking a class of drug once associated with tie-dye and Woodstock seriously as a research frontier, with the potential to reduce death-related anxiety, increase openness to experience, and enhance long-term psychological well-being.
Some of the most prominent results from the past decade of research, in a nutshell:
- LSD: Life satisfaction and well-being remained increased 12 months after a single 200 μg dose. Reduced anxiety and depression in cancer patients, as well as reduced alcohol and tobacco dependency.
- Psilocybin / magic mushrooms: Increased positive affect and reduced trait anxiety at one-month follow-up. Reductions in depression and anxiety symptoms for treatment-resistant depressives.
- Ayahuasca: Reductions in depression, improvements in quality of life, and reduced use of prescription medications for first-time users.
There is, of course, the risk of researcher bias and the placebo effect in these studies; some involve small sample sizes, which beg replication on a larger scale. Nevertheless, the picture painted is overwhelmingly promising, and correlations between subjective reported effects and observed neurochemical changes have been established.
Buy LSD blotters Cyprus, Buy LSD gel tab Luxembourg, Buy Liquid LSD Sweden, DMT crystals, dried liberty caps Denmark, Buy Ketamine Estonia.